Citigroup Downgrades MedAssets To Hold, PT To $20
Citigroup has downgraded MedAssets (NASDAQ: MDAS) from Buy to Hold and has lowered the price target from $26 to $20.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Citigroup medassetsDowngrades Price Target Analyst Ratings